| Absorption |
| Blood-Brain Barrier | BBB+ | 0.9395 |
| Human Intestinal Absorption | HIA+ | 1.0000 |
| Caco-2 Permeability | Caco2+ | 0.8038 |
| P-glycoprotein Substrate | Substrate | 0.6883 |
| P-glycoprotein Inhibitor | Non-inhibitor | 0.6600 |
| Non-inhibitor | 0.8382 |
| Renal Organic Cation Transporter | Inhibitor | 0.5210 |
| Distribution |
| Subcellular localization | Lysosome | 0.4400 |
| Metabolism |
| CYP450 2C9 Substrate | Non-substrate | 0.8238 |
| CYP450 2D6 Substrate | Non-substrate | 0.6170 |
| CYP450 3A4 Substrate | Substrate | 0.6451 |
| CYP450 1A2 Inhibitor | Inhibitor | 0.9107 |
| CYP450 2C9 Inhibitor | Inhibitor | 0.7664 |
| CYP450 2D6 Inhibitor | Non-inhibitor | 0.6229 |
| CYP450 2C19 Inhibitor | Inhibitor | 0.8993 |
| CYP450 3A4 Inhibitor | Inhibitor | 0.7959 |
| CYP Inhibitory Promiscuity | Low CYP Inhibitory Promiscuity | 0.5366 |
| Excretion |
| Toxicity |
| Human Ether-a-go-go-Related Gene Inhibition | Weak inhibitor | 0.9026 |
| Non-inhibitor | 0.9560 |
| AMES Toxicity | Non AMES toxic | 0.7435 |
| Carcinogens | Non-carcinogens | 0.9600 |
| Fish Toxicity | High FHMT | 0.9286 |
| Tetrahymena Pyriformis Toxicity | High TPT | 0.8177 |
| Honey Bee Toxicity | Low HBT | 0.7016 |
| Biodegradation | Not ready biodegradable | 0.5435 |
| Acute Oral Toxicity | III | 0.7155 |
| Carcinogenicity (Three-class) | Non-required | 0.5613 |